Siskinds

Siskinds LLP is a prominent Canadian law firm headquartered in London, Ontario, widely recognized as a leader in class action litigation, particularly within the pharmaceutical and medical device sectors. The firm specializes in representing plaintiffs in high-profile cases involving drug safety, product liability, and failure to warn, often targeting major global pharmaceutical corporations. Siskinds has been at the forefront of significant Canadian litigations and settlements related to opioids, GLP-1 receptor agonists (such as Ozempic and Mounjaro), and various other therapeutic agents linked to undisclosed side effects. With a history dating back to 1937, the firm operates multiple offices across Canada and maintains a specialized affiliate in Quebec to handle provincial civil law matters.